210 related articles for article (PubMed ID: 31286408)
1. Selection of Reference Genes for Normalization of Gene Expression Data in Blood of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3 (MJD/SCA3) Subjects.
Ferreira AF; Raposo M; Vasconcelos J; Costa MDC; Lima M
J Mol Neurosci; 2019 Nov; 69(3):450-455. PubMed ID: 31286408
[TBL] [Abstract][Full Text] [Related]
2. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling in the serums of SCA3/MJD patients.
Shi Y; Huang F; Tang B; Li J; Wang J; Shen L; Xia K; Jiang H
Int J Neurosci; 2014 Feb; 124(2):97-101. PubMed ID: 23879331
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of Mitochondrial DNA Common Deletion Since The Preataxic Stage of Machado-Joseph Disease.
Raposo M; Ramos A; Santos C; Kazachkova N; Teixeira B; Bettencourt C; Lima M
Mol Neurobiol; 2019 Jan; 56(1):119-124. PubMed ID: 29679261
[TBL] [Abstract][Full Text] [Related]
5. Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD).
Haberhausen G; Damian MS; Leweke F; Müller U
J Neurol Sci; 1995 Sep; 132(1):71-5. PubMed ID: 8523034
[TBL] [Abstract][Full Text] [Related]
6. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
7. Machado Joseph-Disease Is Rare in the Peruvian Population.
Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
[TBL] [Abstract][Full Text] [Related]
8. Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease.
Ferreira AF; Raposo M; Shaw ED; Ashraf NS; Medeiros F; Brilhante MF; Perkins M; Vasconcelos J; Kay T; Costa MDC; Lima M
Cells; 2023 May; 12(10):. PubMed ID: 37408238
[TBL] [Abstract][Full Text] [Related]
9. Global DNA methylation is not elevated in blood samples from Machado-Joseph disease mutation carriers.
Teves L; Vieira Melo AR; Ferreira AF; Raposo M; Lemos C; Bettencourt C; Lima M
Epigenetics; 2024 Dec; 19(1):2368995. PubMed ID: 38900099
[TBL] [Abstract][Full Text] [Related]
10. Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3.
Raposo M; Hübener-Schmid J; Ferreira AF; Vieira Melo AR; Vasconcelos J; Pires P; Kay T; Garcia-Moreno H; Giunti P; Santana MM; Pereira de Almeida L; Infante J; van de Warrenburg BP; de Vries JJ; Faber J; Klockgether T; Casadei N; Admard J; Schöls L; ; Riess O; Lima M
Brain; 2023 Oct; 146(10):4132-4143. PubMed ID: 37071051
[TBL] [Abstract][Full Text] [Related]
11. Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD).
Lima M; Raposo M
Adv Exp Med Biol; 2018; 1049():309-319. PubMed ID: 29427111
[TBL] [Abstract][Full Text] [Related]
12. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
[TBL] [Abstract][Full Text] [Related]
13. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
14. Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease.
Raposo M; Bettencourt C; Maciel P; Gao F; Ramos A; Kazachkova N; Vasconcelos J; Kay T; Rodrigues AJ; Bettencourt B; Bruges-Armas J; Geschwind D; Coppola G; Lima M
Mov Disord; 2015 Jun; 30(7):968-75. PubMed ID: 25914309
[TBL] [Abstract][Full Text] [Related]
15. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
16. Mutation detection in Machado-Joseph disease using repeat expansion detection.
Lindblad K; Lunkes A; Maciel P; Stevanin G; Zander C; Klockgether T; Ratzlaff T; Brice A; Rouleau GA; Hudson T; Auburger G; Schalling M
Mol Med; 1996 Jan; 2(1):77-85. PubMed ID: 8900536
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
[TBL] [Abstract][Full Text] [Related]
18. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB
Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
Jia D; Jiang H; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
[TBL] [Abstract][Full Text] [Related]
20. Association between Machado-Joseph disease and oxidative stress biomarkers.
Pacheco LS; da Silveira AF; Trott A; Houenou LJ; Algarve TD; Belló C; Lenz AF; Mânica-Cattani MF; da Cruz IB
Mutat Res Genet Toxicol Environ Mutagen; 2013 Oct; 757(2):99-103. PubMed ID: 23994570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
